title: [No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression].
authors.affiliation: Department of Radiation Oncology, University Hospital Zurich (USZ), Rämistraße 100, 8091, Zurich, Schweiz.
authors.forename: Helena
authors.initials: H
authors.lastname: Garcia Schüler
authors.affiliation: Department of Radiation Oncology, University Hospital Zurich (USZ), Rämistraße 100, 8091, Zurich, Schweiz. Matthias.Guckenberger@usz.ch.
authors.forename: Matthias
authors.initials: M
authors.lastname: Guckenberger
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000097:blood; D003131:Combined Modality Therapy / Q000401:mortality / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000401:mortality* / Q000532:radiotherapy*; D015995:Prevalence; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000401:mortality* / Q000706:statistics & numerical data; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality* / Q000628:therapy*; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen